LatticePoint Experience

Therapeutic and Global Experience

LatticePoint has been working with clients and major industry players for decades ranging from rare diseases, medical devices and a range of therapeutic areas. Our clients trust our world-class team of market access leader’s experience in the sciences, industry, venture capital and negotiations assess your product in the marketplace.

We have helped companies of all sizes and situations

  • Big Pharma

  • Emerging biopharma

  • Investors

  • BD/In-licensing teams

A range of therapeutic areas

Rare Diseases and/or Orphan Designation:


  • Relapse/refractory neuroblastoma
  • Acute lymphoblastic/myeloid leukemia


  • Haemophilia-A and –B
  • Beta-thalassemia (gene therapy)
  • Hereditary Angioedema

Autoimmune diseases

  • Idiopathic thrombocytopenic purpura (ITP)
  • Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID – gene therapy)


  • Primary hyperparathyroidism
  • Hypoparathyroidism


  • Cystic fibrosis
  • Homozygous familial hypercholesterolaemia (oral, biologic)
  • Severe veno-occlusive disease
  • Duchenne Muscular Dystrophy (3-products)
  • Lysomsomal Storage Disorders (Gaucher, Fabry – biologic, oral)
  • Pompe Disease (biologic)
  • Hunner’s lesions (interstitial cystitis)
  • Calciphylaxis

Non-orphan Therapeutic Areas


  • Alzeimer’s disease
  • Parkinson’s disease
  • Multiple sclerosis
  • Psoriasis (oral, biologic)
  • Rheumatoid arthritis (biologic)
  • Oncology, including bladder, pancreatic, breast, ovarian, neuroblastoma
  • Hereditary ATTR amyloidosis (biologic)
  • wet-AMD, Retinal Vein Occlusion, Diabetic Macular Edema
  • Acute, chronic Pain / Uremic Pruritus
  • Systemic Lupus Erythematosus
  • Bronchiolitis Obliterans
  • Stroke Prevention/Thrombosis
  • Pain (Neuropathic, osteoarthritis, opioid, NGFi)
  • Antibiotics
  • Hepatitis C

Medical devices/Non-drug intervention

  • Endomicroscopy system
  • Wound care dressings
  • Laser Cataract Surgery
  • Fertility products
  • Nutrition products

Global negotiation experience

At LatticePoint, we have in-country experience working with, and on behalf of, our clients who require on-the-ground assistance. Our multilingual staff of native German, French, Italian, Spanish and English speakers is experienced at handling negotiations in many key countries while keeping an eye on cross-border implications. We engage with payers, providers, HTA bodies and EMA for early access, give feedback on clinical program design, and conduct in-country reimbursement negotiations in key markets around the world. We also retain a Global Payer Panel for market research. 

We have a multilingual staff of native German, French, Italian, Spanish, Portuguese and English speakers who have negotiated on behalf of our clients. A quality that is unique in the industry; that’s what we do.